Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aurelielaugraud
    Member
    • Aug 2009
    • 37

    #1

    Software developer in bioinformatics in Lyon, France

    1-PROGRAMME

    1.1 Description of duties

    Working in a team of experienced bioinformaticians and in close collaboration
    with French partner groups and international research centers, the candidate
    will :

    -- apply his thorough experience in software development
    -- provide thoughtful and precise recommendations regarding programming
    choices and implementation model issues
    -- contribute to the challenges of efficiently processing, analyzing and
    visualizing the huge volume of data generated by new high throughput DNA
    sequencing methods
    -- be a major player in designing and writing softwares in accordance with
    high quality insurance standard
    -- collaborate with investigators trained in mathematics, statistics,
    computer sciences and genomics

    1.2 Context

    INCa-Synergie Lyon Cancer is bioinformatics facility platform dedicated to
    the next generation sequencing technologies in the field of cancer genomics.
    Recognizing the new opportunities offered by next generation sequencing
    technologies for cancer genomics, the French National Cancer Institute (INCa)
    has pledged to provide a major contribution to the International Cancer
    Genome Consortium (ICGC- http://www.icgc.org/) through the study of several
    cancer types.
    In order to overcome the challenges raised by the massive amount of sequence
    data that has been and will be generated, INCa and the Lyon community through
    the Synergie Lyon Cancer Foundation (http://www.synergielyoncancer.fr/) are
    joining efforts to create a dedicated bioinformatics facility. The objective
    of the bioinformatics facility will be to empower the biomedical teams
    working in the field of cancer to best exploit the data generated through
    large scale genomic projects, notably those funded by INCa and in the first
    place those taking place within the ICGC. Pr. Gilles Thomas is the director
    of the facility.

    The INCa-Synergie facility is located in a major French comprehensive cancer
    center (Centre Leon Berard) with a very active research department
    (http://oncora1.lyon.fnclcc.fr/englis...index_eng.html). It is in
    close proximity to the International Agency for Research on Cancer, IARC. The
    facility is integrated into the "Pole Rhone-Alpes de Bioinformatique, PRABI
    (http://www.prabi.fr/), which federates major regional bioinformatics teams.
    Thus the facility benefits both from strong biomedical and bioinformatics
    environments. It has acquired and is extending a large HPC equipment. The
    present staff includes two bioinformaticians, two biostatisticians and one
    database manager. A new position is opened for an experienced software
    developer.


    2- REQUIRED QUALIFICATION

    2.1 Education

    Advanced university degree (Masters, PhD) in computer science.

    Required skills :

    -- GNU/Linux environment
    - mastering at least one of the following programming languages : J2EE, C,
    C++.
    -- advanced knowledge of some major script languages (shell, awk, perl,
    python, ruby) and web languages (php, ajax, javascript, XML).
    -- Capacity of contributing the computer methods of interest for
    bioinformatics analysis.
    -- Knowledge of database development (postgreSQL, MySQL)



    Additional skills that would be appreciated

    -- Optimizing, parallelizing algorithms (knowledge or experience in
    multithreaded programming).
    -- Previous experience in system management
    -- Basic knowledge of R
    -- Basic knowledge of genomics


    2.3 Professional experience

    At least two years of relevant professional experience in the field of
    computer science.

    2.4 Complementary information

    Excellent interpersonal skills are essential. The candidate should be self
    motivated, capable of working both independently and within a closely
    interacting team of scientists and be able to deliver a quality product with
    fixed deadlines. Oral and written communication in the group is in English.


    3- CONTRACT AND SUBMISSION PROCEDURE

    3.1 Contract

    Fixed term appointment (34 months) will be offered to the successful
    candidate. Starting date may be immediate. The salary will be based on the french public research institution
    wages and adjusted according to the successful candidate experience.

    3.2 Work location

    Lyon, France

    3.3 Submission procedure

    Letter of motivation, curriculum vitae and addresses of three referees are to
    be provided in electronic form to the following e-mail address :
    [email protected] before July 31st 2011. Acknowledgement of
    receipt will be forwarded to each candidate. Selected candidates will be
    invited to come to Lyon, France for an interview. General enquiries about the
    open position may be sent to the same e-mail address.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
41 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
74 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...